These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1053 related articles for article (PubMed ID: 29516506)

  • 41. Potential of semen coicis in enhancing the anti-tumor effects of PD-1 inhibitor on A549 cell lines by blocking the PI3K-AKT-mTOR pathway.
    Fu ZY; Huang Y; Lian LS; Huang HT; Zhan SF; Cai Y; Li JX; Liu XH
    Clin Transl Oncol; 2024 Sep; 26(9):2250-2261. PubMed ID: 38554191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Programmed Cell Death Ligand 1 Expression in Resected Lung Adenocarcinomas: Association with Immune Microenvironment.
    Huynh TG; Morales-Oyarvide V; Campo MJ; Gainor JF; Bozkurtlar E; Uruga H; Zhao L; Gomez-Caraballo M; Hata AN; Mark EJ; Lanuti M; Engelman JA; Mino-Kenudson M
    J Thorac Oncol; 2016 Nov; 11(11):1869-1878. PubMed ID: 27568346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.
    Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H
    Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PD-L1 upregulation by IFN-α/γ-mediated Stat1 suppresses anti-HBV T cell response.
    Liu L; Hou J; Xu Y; Qin L; Liu W; Zhang H; Li Y; Chen M; Deng M; Zhao B; Hu J; Zheng H; Li C; Meng S
    PLoS One; 2020; 15(7):e0228302. PubMed ID: 32628668
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional loss of ARID1A is tightly associated with high PD-L1 expression in gastric cancer.
    Kim YB; Ahn JM; Bae WJ; Sung CO; Lee D
    Int J Cancer; 2019 Aug; 145(4):916-926. PubMed ID: 30664822
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor Interferon Signaling Is Regulated by a lncRNA INCR1 Transcribed from the PD-L1 Locus.
    Mineo M; Lyons SM; Zdioruk M; von Spreckelsen N; Ferrer-Luna R; Ito H; Alayo QA; Kharel P; Giantini Larsen A; Fan WY; Auduong S; Grauwet K; Passaro C; Khalsa JK; Shah K; Reardon DA; Ligon KL; Beroukhim R; Nakashima H; Ivanov P; Anderson PJ; Lawler SE; Chiocca EA
    Mol Cell; 2020 Jun; 78(6):1207-1223.e8. PubMed ID: 32504554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MAPK pathway activity plays a key role in PD-L1 expression of lung adenocarcinoma cells.
    Stutvoet TS; Kol A; de Vries EG; de Bruyn M; Fehrmann RS; Terwisscha van Scheltinga AG; de Jong S
    J Pathol; 2019 Sep; 249(1):52-64. PubMed ID: 30972766
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours.
    Martin V; Chiriaco C; Modica C; Acquadro A; Cortese M; Galimi F; Perera T; Gammaitoni L; Aglietta M; Comoglio PM; Vigna E; Sangiolo D
    Br J Cancer; 2019 Mar; 120(5):527-536. PubMed ID: 30723303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of mitogen-activated protein kinase pathway can induce upregulation of human leukocyte antigen class I without PD-L1-upregulation in contrast to interferon-γ treatment.
    Mimura K; Kua LF; Shiraishi K; Kee Siang L; Shabbir A; Komachi M; Suzuki Y; Nakano T; Yong WP; So J; Kono K
    Cancer Sci; 2014 Oct; 105(10):1236-44. PubMed ID: 25154680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
    Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y
    J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prostasin regulates PD-L1 expression in human lung cancer cells.
    Chen LM; Chai JC; Liu B; Strutt TM; McKinstry KK; Chai KX
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34240739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IFN-γ activates the tumor cell-intrinsic STING pathway through the induction of DNA damage and cytosolic dsDNA formation.
    Xiong H; Xi Y; Yuan Z; Wang B; Hu S; Fang C; Cai Y; Fu X; Li L
    Oncoimmunology; 2022; 11(1):2044103. PubMed ID: 35273829
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells.
    Coombs MRP; Harrison ME; Hoskin DW
    Cancer Lett; 2016 Oct; 380(2):424-433. PubMed ID: 27378243
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IFN-gamma-induced BACE1 expression is mediated by activation of JAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes.
    Cho HJ; Kim SK; Jin SM; Hwang EM; Kim YS; Huh K; Mook-Jung I
    Glia; 2007 Feb; 55(3):253-62. PubMed ID: 17091494
    [TBL] [Abstract][Full Text] [Related]  

  • 55. B7-H4 is increased in lung adenocarcinoma harboring EGFR-activating mutations and contributes to immunosuppression.
    Lu Y; Wu F; Cao Q; Sun Y; Huang M; Xiao J; Zhou B; Zhang L
    Oncogene; 2022 Jan; 41(5):704-717. PubMed ID: 34839353
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CXCL5 impedes CD8
    Sun D; Tan L; Chen Y; Yuan Q; Jiang K; Liu Y; Xue Y; Zhang J; Cao X; Xu M; Luo Y; Xu Z; Xu Z; Xu W; Shen M
    J Exp Clin Cancer Res; 2024 Jul; 43(1):202. PubMed ID: 39034411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. E3 ubiquitin ligases Cbl-b and c-Cbl downregulate PD-L1 in EGFR wild-type non-small cell lung cancer.
    Wang S; Xu L; Che X; Li C; Xu L; Hou K; Fan Y; Wen T; Qu X; Liu Y
    FEBS Lett; 2018 Feb; 592(4):621-630. PubMed ID: 29364514
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical importance of VEGFC and PD-L1 co-expression in lung adenocarcinoma patients.
    Qin T; Xia J; Liu S; Wang J; Liu H; Zhang Y; Jia Y; Li K
    Thorac Cancer; 2020 May; 11(5):1139-1148. PubMed ID: 32154654
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thymosin β10 promotes tumor-associated macrophages M2 conversion and proliferation via the PI3K/Akt pathway in lung adenocarcinoma.
    Zeng J; Yang X; Yang L; Li W; Zheng Y
    Respir Res; 2020 Dec; 21(1):328. PubMed ID: 33349268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy.
    Xi J; Huang Q; Wang L; Ma X; Deng Q; Kumar M; Zhou Z; Li L; Zeng Z; Young KH; Zhang M; Li Y
    Oncogene; 2018 Jun; 37(23):3151-3165. PubMed ID: 29540832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.